lopinavir r arm

Related by string. * Lopinavir : Kaletra lopinavir ritonavir . lopinavir ritonavir Kaletra . lopinavir ritonavir plus . Lopinavir Ritonavir . lopinavir ritonavir / red . Rs . R. . Rd . ring : Rs #.# [005] . Bill Frist R Tenn . R Ind . RED FLAG WARNING WHICH . Toys R Us / AD RMS . arms . arming . ARM . Arms : Combined Arms Center . Army Combined Arms . left arm spinner . UN arms embargo . attempted armed robbery * *

Related by context. All words. (Click for frequent words.) 83 REYATAZ r arm 81 PREZISTA r arm 79 oxycodone CR 77 mcg QD 77 4mg/kg 77 comparator arm 77 PREZISTA ritonavir 75 mcg BID 75 ACTEMRA TM 75 8mg/kg 75 placebo dexamethasone 75 achieved ACR# 75 HBeAg negative patients 75 plus methotrexate 75 adjunctive placebo 74 generalized edema 74 #mg BID [001] 74 leukopenia 74 mg QD 74 hypophosphatemia 74 â ‰ ¥ 74 lopinavir r 74 mg BID 74 mcg albinterferon alfa 2b 73 FluCAM arm 73 plus dexamethasone 73 Peg IFN 73 dapagliflozin plus 73 aminotransferase elevations greater 72 nasopharyngitis 72 Flu Cy 72 p = NS 72 mg TID 72 HBeAg seroconversion 72 neutropaenia 72 morphometric vertebral fractures 72 alfa 2a 72 FOLFOX4 72 FOLFOX4 alone 72 nadroparin 72 TEAEs 72 q#h 72 mg ustekinumab 72 receiving ISENTRESS 72 peripheral sensory neuropathy 72 laboratory abnormalities 72 mg qd 72 tipranavir r 71 events AEs 71 #.#mg/dL 71 oral allopurinol 71 hematologic toxicity 71 ug dose 71 % CI #.#-#.# [003] 71 ABC/3TC 71 fatigue asthenia 71 tapentadol ER 71 amoxicillin clavulanate 71 clodronate 71 severe neutropenia 71 CIMZIA TM 71 Viread Emtriva Sustiva 71 receiving VICTRELIS 71 mg BID dose 71 5-FU/LV 71 -#.# log# 71 PREZISTA r 71 ertapenem 71 discontinuations due 71 oxycodone IR 71 TMC# r 70 neutropenia dehydration dyspnea 70 ALVESCO 70 LPV r 70 experienced virologic failure 70 diarrhea nausea fatigue 70 Engerix B 70 mcg kg REBETOL 70 HBeAg positive patients 70 FOLPI 70 aspartate aminotransferase 70 LEXIVA r 70 peginterferon alfa 2a 70 pooled comparator 70 chlorambucil 70 pyrexia mucositis sepsis febrile 70 log# copies mL 70 receiving PEGINTRON 70 BARACLUDE ® 70 plus OBT 70 budesonide pMDI 70 hypokalemia 70 ritonavir boosted atazanavir 70 Acetate Rectal Suppositories 70 lumbar spine BMD 70 rizatriptan 70 unresectable HCC 70 CCyR 70 peripheral edema 70 mcg linaclotide 70 receiving golimumab 70 REMICADE monotherapy 70 placebo p = 70 ALT elevation 70 lispro 70 biologic DMARD 70 octreotide LAR 69 adjunctive ABILIFY 69 plus gemcitabine 69 achieved CCyR 69 highly emetogenic 69 IIIa inhibitors 69 #mg/m# [001] 69 saline placebo 69 #mg/day [001] 69 % CI #.#-#.# [007] 69 infliximab monotherapy 69 3mg/kg 69 mcg mL 69 PEG Interferon alfa 69 Viread Emtriva SUSTIVA 69 receiving prophylactic anticoagulation 69 mcg Albuferon 69 nondiabetic patients 69 myalgia arthralgia 69 CIMZIA ™ 69 biochemical relapse 69 pegylated interferon alfa 2b 69 plus GP IIb 69 SGPT 69 CIMZIA TM certolizumab pegol 69 -#.# mg dL [002] 69 Pred Forte 69 insulin detemir 69 mg/m2 dose 69 ribavirin RBV 69 mcg kg 69 acneform rash 69 virologic failure 69 x ULN 69 q8h 69 Index CDAI 69 tolterodine ER 69 ACR# response 69 transaminase elevations 69 febrile neutropenia 69 receiving INTRON 69 DOXIL 69 diarrhea nausea vomiting 69 CR nPR 69 APTIVUS r 69 Pegasys ® 69 CANCIDAS 69 deep venous thromboses 69 Median PFS 69 salmeterol fluticasone 69 FOLFOX 69 moderate renal impairment 69 alanine aminotransferase 69 R adefovir dipivoxil 69 fluticasone salmeterol 69 mg m² 69 aspartate aminotransferase AST 69 neutropenia thrombocytopenia 69 Psoriasis Area 68 -#.# log# copies mL 68 piperacillin tazobactam 68 hours postdose 68 arterial thromboembolic events 68 certolizumab 68 benazepril 68 P = .# 68 lumbar spine bone 68 Infusion Reactions Severe 68 leucopenia 68 PROCTOCORT ® Suppository Hydrocortisone 68 binary restenosis 68 incidence ≥ 68 ARCALYST ® 68 interferon alfa 2a 68 zolmitriptan 68 atazanavir ritonavir 68 KRAS mutations occur 68 asthenia 68 metastatic GIST 68 preintervention 68 μg dose 68 sumatriptan naproxen sodium 68 QTcF 68 zonisamide SR 68 ARCOXIA 68 ALT flares 68 #mg dose [002] 68 linaclotide treated 68 mg kg dose 68 MCyR 68 flutamide 68 unfractionated heparin UFH 68 Mg Uk 68 Viread Emtriva 68 doxazosin 68 PASI scores 68 RLAI 68 ritonavir boosted 68 BUPHENYL 68 achieved PASI 68 COMBIVIR 68 HBeAg positive 68 PEG Intron 68 Crohn Disease Activity 68 imipenem 68 evaluable subjects 68 desvenlafaxine succinate 68 XIENCE V PROMUS Stent 68 Folfox 68 NPH insulin 68 MADRS score 68 alanine aminotransferase ALT 68 tolvaptan 68 elevated ALT 68 lamivudine monotherapy 68 nodular partial response 68 tapentadol IR 68 TAXUS p value 68 nicardipine 68 corticosteroid dose 68 oral diclofenac 68 FOLFOX6 68 mg RDEA# 68 FOLFIRI 68 mg q#h 68 rectal tenesmus 68 peginterferon alfa 2a Pegasys 68 neutropenia anemia 68 dacarbazine 67 titrated glipizide 67 % Confidence Interval 67 events SAEs 67 REYATAZ r 67 receiving XGEVA 67 solifenacin 67 bivalirudin monotherapy 67 lymphopenia 67 mg Lucentis 67 HBeAg negative 67 Paraplatin ® 67 splenectomized 67 FluCAM 67 doxorubicin cyclophosphamide 67 headache nasopharyngitis 67 adriamycin 67 tamsulosin 67 relapsed MM 67 severe exacerbations 67 μg kg 67 PRADAXA #mg 67 undetectable HBV DNA 67 #mg doses [002] 67 hip BMD 67 SVR# 67 GERD symptom 67 mL/min/#.# m 2 67 NATRECOR R 67 headache abdominal pain 67 mg tid 67 #mg #mg #mg [003] 67 normal ULN 67 nadolol 67 abacavir lamivudine 67 patients receiving ERBITUX 67 response CCyR 67 PEGASYS ® 67 experienced hypomagnesemia 67 Hypomagnesemia occurred 67 asthenia fatigue 67 HCV RESPOND 2 67 low dose Iluvien 67 rimonabant #mg/day 67 FOLFIRI alone 67 ULORIC 67 microbiological eradication 67 Scale EDSS score 67 pegylated interferon alfa 2a 67 constipation nausea 67 #mg QD [001] 67 anemia hemoglobin 67 FFNS 67 baseline HbA1c 67 rosuvastatin #mg 67 ACR# ACR# 67 plus 5-FU/LV 67 microgram kg 67 CYPHER Stent 67 carboplatin paclitaxel 67 Zometa hazard 67 SGOT 67 oral levofloxacin 67 enalapril 67 CI -#.# 67 BENICAR HCT 67 pharyngolaryngeal pain 67 doripenem 67 placebo PBO 67 PROCTOCORT R 67 #.#/#.# mmHg [001] 67 virologic breakthrough 67 mg/m2/day 67 mg eq 67 kBq kg 67 -#.# mg dL [001] 67 receiving Vectibix monotherapy 67 Fludara 67 baseline A1C 67 steroid dexamethasone 67 X ULN 67 microg 67 Peginterferon Alfa 2a 67 placebo p 67 dizziness nausea diarrhea 67 nonsignificant difference 67 PEGINTRON TM 67 IRLS score 67 daunorubicin 67 Cream USP 1 66 micrograms mL 66 cEVR 66 #mg/day [002] 66 ARIXTRA 66 EUFLEXXA R 66 Thal Dex 66 p = ns 66 #Gy 66 PREMPRO 66 mg Proellex 66 cisplatin vinorelbine 66 receiving VELCADE 66 valsartan amlodipine 66 stage IIIb IV 66 subcutaneous enoxaparin 66 IELT 66 adefovir treated 66 PREZISTA rtv 66 p = .# [001] 66 urate lowering therapy 66 mcg doses 66 -#.# ± [002] 66 placebo fluoxetine 66 Elitek 66 CI #.#-#.# [001] 66 ropivacaine 66 hypoglycemic events 66 MIC# [001] 66 nevirapine Viramune 66 log# reduction 66 paresthesias 66 adefovir 66 prednisone prednisolone plus 66 posaconazole 66 pT3 66 Navelbine 66 alpha interferons 66 mild renal insufficiency 66 amprenavir 66 active comparator 66 TLUS 66 tenofovir emtricitabine 66 #mg q8h 66 peginterferon alfa 2b 66 severe NCI CTC 66 virologic response 66 TDF FTC 66 neutropenia febrile neutropenia 66 postmenopausal osteoporotic women 66 elevated lipase 66 ug kg 66 % CI #.#-#.# [006] 66 candesartan cilexetil 66 primary hypercholesterolemia 66 Doxil ® 66 superficial edema 66 dalteparin 66 stomatitis pharyngitis 66 #.#g/day 66 acarbose 66 confidence interval #.#-#.# 66 AZT zidovudine Retrovir 66 ‰ ¥ 66 mg Androxal 66 dacarbazine DTIC 66 stomatitis 66 weekly CSBMs 66 dysuria 66 INCB# [003] 66 #mg QD [002] 66 IBDQ 66 adverse reactions occurring 66 abacavir sulfate lamivudine 66 pegIFN 66 TPV r 66 interferon alfa 2b 66 VELCADE melphalan 66 serum aminotransferase levels 66 #mg BID [003] 66 biphasic insulin aspart 66 voriconazole 66 events MACE 66 pyrexia 66 Lantus ® 66 HbA 1c levels 66 COPD exacerbation 66 PEGylated anti 66 DAS# CRP 66 salmeterol fluticasone propionate 66 tacrolimus ointment 66 μmol L 66 undetectable viral 66 definite stent thrombosis 66 antiretroviral naïve 66 Q2W 66 log# IU mL 66 mCRC acneform rash 66 plus prednisone 66 humanized interleukin 6 66 mucosal inflammation 66 pruritus itching 66 Insulin Glargine 66 Ishak fibrosis score 66 VANOS TM fluocinonide Cream 66 TMP SMX 66 Oral Fingolimod 66 Telithromycin 66 hematologic adverse 66 oral antidiabetic medication 66 recurrent VTE 66 Stomatitis 66 Pegasys peginterferon alfa 2a 66 incontinence episodes 66 myelodysplastic myeloproliferative diseases 66 mean baseline A1C 65 non splenectomized 65 Mg Usa 65 alfuzosin 65 atazanavir sulfate 65 dosing cohorts 65 sUA 65 NovoLog ® Mix 65 efavirenz EFV 65 infection nasopharyngitis 65 hypomagnesemia 65 fosamprenavir 65 ARB telmisartan 65 plus aztreonam 65 TAXUS Express Stent 65 conjunctival hyperemia 65 HBeAg 65 RGT arm 65 BENCHMRK 65 proctitis 65 bone marrow reticulin deposition 65 CDAI score 65 IFN alfa 65 cells uL 65 treatment emergent adverse 65 PEGINTRON REBETOL groups 65 plus glycoprotein IIb 65 COZAAR 65 mg hydrochlorothiazide 65 μg doses 65 Score TOS 65 FUSILEV enhances 65 nasopharyngitis headache 65 Scale EDSS 65 diuretic chlorthalidone 65 trimethoprim sulfamethoxazole 65 serum phosphorous 65 statin monotherapy 65 arthralgia 65 ATACAND 65 achieved statistical significance 65 pegylated interferon alpha 65 HIV RNA 65 chills fever headache 65 TAXOTERE R 65 creatinine clearance 65 advanced adenomas 65 ribavirin therapy 65 Fasting blood glucose 65 β blocker 65 nonvertebral fractures 65 gout flares 65 REYATAZ ritonavir 65 Apidra ® 65 valacyclovir 65 mg simvastatin 65 severe renal impairment 65 VaD 65 PegIntron 65 recurrent genital herpes 65 achieving PASI 65 Expanded Disability Status 65 recurrent glioblastoma multiforme 65 seroconverted 65 nasopharyngitis upper 65 serum phosphate 65 annualized relapse 65 del 5q MDS 65 treatment naïve genotype 65 fasting plasma glucose FPG 65 complete cytogenetic response 65 mg/m2 IV 65 spontaneous bowel movements 65 abdominal pain flatulence 65 naïve HCV 65 beclomethasone dipropionate 65 transaminases 65 serum urate levels 65 MACCE 65 inhaled fluticasone 65 somatostatin analog 65 ribavirin USP 65 heFH 65 R# #mg BID 65 anthracycline taxane 65 intravitreal injections 65 methotrexate monotherapy 65 mg dose 65 postintervention 65 glimepiride 65 nucleoside naive 65 Hycamtin ® 65 serum prostate 65 ARICEPT 65 hydroxymethyl coenzyme 65 ibandronate 65 aminotransferases 65 mitoxantrone plus 65 #mg dosing group 65 Peginterferon 65 nausea somnolence 65 somnolence dizziness 65 glipizide plus 65 ALT elevations 65 serum urate 65 prednisone prednisolone 65 CRESTOR #mg 65 mg administered orally 65 p = #.# [002] 65 Rating Scale MADRS 65 ng dL 65 lipid lowering agents 65 rFSH 65 rimonabant #mg 65 tamoxifen Nolvadex ® 65 evaluating tivozanib 64 hypertrichosis occurred 64 gastrointestinal perforation 64 interferon alfa 64 tirofiban 64 YERVOY 64 mCi kg 64 diarrhea vomiting rash 64 baseline serum creatinine 64 ethambutol 64 ischemia driven 64 #mmHg [001] 64 Copegus 64 partial remissions 64 advanced adenoma 64 peginterferon alfa 64 erosive gastritis 64 HYZAAR 64 NATRECOR ® 64 atorvastatin #mg 64 adverse reactions observed 64 pimecrolimus cream 64 cytogenetic response 64 alemtuzumab treated 64 NNT = 64 extrapyramidal symptoms 64 zidovudine lamivudine 64 BUPHENYL R sodium phenylbutyrate 64 #ug [001] 64 salmeterol inhalation powder 64 INVANZ 64 SPRYCEL ® 64 median PFS 64 plasma uric acid 64 reinfarction 64 vincristine doxorubicin 64 administered subcutaneously 64 p ≤ 64 IU mL 64 virologic failures 64 brand ciclesonide HFA 64 Taxus Stent 64 mycophenolate mofetil 64 mg d 64 hyperphenylalaninemia HPA due 64 telaprevir dosing 64 #mg/m# [002] 64 achieved mucosal healing 64 mucositis stomatitis 64 #μg [001] 64 PegIFN RBV 64 ALT normalization 64 Lupuzor ™ 64 candidemia 64 baseline Hb 64 Serious adverse reactions 64 VIIBRYD 64 sustained virologic response 64 Dermatologic toxicities 64 interferon ribavirin 64 micafungin 64 #μg [002] 64 CI #.#-#.# [002] 64 AGILECT R 64 indinavir 64 palmar plantar 64 subtrochanteric 64 Operative mortality 64 mL/min/#.# m2 64 transaminase elevation 64 FEMALES SHOULD BE ADVISED 64 quetiapine risperidone 64 hematologic toxicities 64 ALN HPN 64 dermatologic toxicities 64 injected subcutaneously 64 uncoated stent 64 IU ml 64 Montgomery Asberg Depression 64 idraparinux 64 timepoint 64 T2 lesion volume 64 hepatorenal syndrome 64 urinary N telopeptide 64 ECOG PS 64 CrCl 64 headache nausea diarrhea 64 SPIRIVA ® 64 % CI #.#-#.# [008] 64 LANTUS R 64 risedronate Actonel 64 Newly Diagnosed Multiple Myeloma 64 XIENCE V demonstrated 64 hepatitis C genotype 64 glyburide 64 docetaxel prednisone 64 #mg dose [003] 64 mmHg diastolic 64 dose cohort 64 Pharmacokinetic parameters 64 mg + GLY 64 abdominal pain abdominal discomfort 64 Fasting plasma glucose 64 arthralgias 64 lopinavir ritonavir 64 p = .# [002] 64 stage IIIB 64 TNF Tumor Necrosis Factor 64 PSA nadir 64 ceftazidime 64 fluorouracil leucovorin 64 Index CDAI score 64 oral olanzapine 64 Aptivus ® 64 See WARNINGS 64 + PH# 64 #mg/kg [002] 64 p = #.# [003] 64 EDSS scores 64 plus prednisone prednisolone 64 pruritis 64 64 mcg dose 64 mitoxantrone 64 prospectively stratified 64 oblimersen 64 OAB symptoms 64 cisplatin gemcitabine 64 mm Hg systolic 64 tobramycin inhalation solution 64 IV bolus 64 sirolimus eluting stent 64 chemoradiation therapy 64 DETROL LA 64 GOUT 64 Zorbtive TM 64 intra articular injection 64 isoproterenol 64 genotype 1b 64 mCi m 2 64 cytologically confirmed 64 gemcitabine cisplatin 64 BENICAR 64 headache diarrhea nausea 64 Pooled Analysis 64 titrated glipizide plus 64 metformin IR 64 Chronic Hepatitis C 64 PROCTOCORT ® Cream Hydrocortisone 64 5mg/kg 64 tipranavir ritonavir 64 acute bipolar mania 64 nmol l 64 mg/# mg [001] 64 ximelagatran 64 bleeding pallor 64 Complicated Skin 64 daily Infergen 64 Copegus ribavirin 64 TO AVOID PREGNANCY WHILE 64 angioneurotic edema 64 ACR# responses 64 patients evaluable 64 pericardial effusions 64 docetaxel chemotherapy 64 AEGR 64 metabolic alkalosis 64 oral rivaroxaban 64 invasive aspergillosis 64 DAS# [002] 64 binary restenosis rate 64 tenofovir FTC 64 VIRAMUNE 64 hour bronchodilation 64 Relapsing Multiple Sclerosis 64 refractory NSCLC 64 rFVIIa 64 myalgia 64 corticosteroid therapy 64 zoledronate 64 potent CYP#A# inhibitors 64 ELOXATIN 64 mU liter 64 ketorolac 64 dexamethasone Decadron 64 diameter stenosis 64 lamivudine refractory patients 63 haematologic 63 neutrophil counts 63 lenalidomide Revlimid R 63 invasive carcinomas 63 telaprevir dosed 63 Perforomist Inhalation Solution 63 EDSS score 63 abdominal distention 63 #.#/#.# mm Hg [003] 63 Neutropenia 63 events TEAEs 63 β blockers 63 CLINICAL STUDIES 63 Copegus ® 63 RECIST Response Evaluation Criteria 63 mIU ml 63 mmol l 63 Myocardial Infarction Study 63 Adefovir 63 Amgen Neulasta R 63 symptomatic VTE 63 baseline FEV 63 mg orally 63 Betaferon R 63 EXJADE 63 nonfatal MI 63 liposome injection 63 malignancy HCM 63 BUPHENYL ® sodium phenylbutyrate 63 calculated creatinine clearance 63 non menstrual pelvic 63 Losartan Potassium 63 mg/# hours 63 Diovan Exforge Tekturna Zelnorm 63 fluvastatin 63 epistaxis 63 plus ribavirin 63 AVODART 63 Hb A1C 63 mL kg 63 severe hypoglycemic 63 glulisine 63 Myelodysplastic Syndrome MDS 63 elevated transaminases 63 R Saizen R 63 pegylated liposomal doxorubicin 63 unfractionated heparin 63 EPIVIR 63 sirolimus stent 63 lispro alone 63 infusional 5-FU/LV 63 Soriatane R 63 serum creatinine levels 63 bortezomib refractory 63 DOXIL ® 63 Hypotension 63 complete cytogenetic 63 imipramine Tofranil 63 mg kg belimumab 63 COPEGUS 63 aspirin heparin 63 IOP lowering 63 5 FU leucovorin 63 neutropenic fever 63 MYCAMINE 63 metformin monotherapy 63 MoxDuo TM IR 63 Non inferiority 63 adalimumab Humira 63 dyspareunia 63 detemir 63 ecchymosis 63 p = #.# [004] 63 clinically evaluable patients 63 Febrile neutropenia 63 nonvertebral 63 REVLIMID ® 63 tazobactam 63 neuropathy sensory 63 #.#mg/kg [002] 63 Contrave# 63 STELARA ® 63 hematological adverse 63 low dose cytarabine 63 STN stimulation 63 lopinavir 63 Patency 63 mmHg systolic 63 acromegalic patients 63 pegylated interferon alfa 63 Adverse events 63 rash desquamation 63 Nebulized 63 recurrent venous thromboembolism 63 mg p = 63 virological failure 63 colorectal adenoma 63 serum IGF 63 receiving highly emetogenic 63 hip femoral neck 63 mm Stent 63 TNF antagonists 63 Refractory Hodgkin Lymphoma 63 recurrent DVT 63 urine albumin 63 tertile 63 divalproex sodium 63 Severity Index PASI 63 postdose 63 fluoxetine paroxetine 63 overt nephropathy 63 OS = ISD/#/#/# 63 Adalimumab 63 confidence interval CI 63 LEXIVA 63 ZYVOX 63 Tipranavir 63 elevated LDH 63 plus COPEGUS 63 HbA1c levels 63 interferon alpha Severe 63 Alkeran 63 deferoxamine 63 elevated serum creatinine 63 included neutropenia anemia 63 milliliters mL 63 nocturnal awakenings 63 cytogenetic responses 63 LOVENOX 63 efavirenz emtricitabine 63 sorafenib tablets 63 log# 63 Omiganan 63 REYATAZ ® 63 peginterferon alfa 2a #KD 63 seroprotection 63 plus MTX 63 GnRH agonist 63 clozapine Clozaril 63 Nilotinib 63 Pegylated interferon 63 glycated hemoglobin levels 63 #-#,# mg 63 squamous histology 63 moderately emetogenic 63 Vfend 63 QD dosing 63 Severe cutaneous 63 adalimumab 63 neurodevelopmental impairment 63 scores TNSS 63 mg kg ip 63 Is Well Tolerated 63 Posaconazole 63 treatment naive genotype 63 ACE Inhibitors 63 Antitumor Activity 63 IXEMPRA 63 pyridostigmine 63 paclitaxel cisplatin 63 CIN3 63 CTAP# Capsules 63 1mg 2mg 63 splenectomized patients 63 venlafaxine Effexor 63 baseline LDH 63 CDAI 63 moderate hepatic impairment 63 ® fluocinonide Cream 63 #.#mg 1mg 63 rosuvastatin Crestor 63 peg interferon 63 REBETOL 63 oral vancomycin 63 #mg/#mg 63 abdominal pain headache 63 ezetimibe simvastatin 63 prolonged QT interval 63 occlusion PAO 63 Response Evaluation Criteria 63 trastuzumab Herceptin R 63 Montgomery Åsberg Depression 63 NEUPOGEN R 63 IFN α 63 Navelbine ® 63 mg XP# 63 Myelosuppression 63 gout flare 63 UPDRS motor 63 interferon alfacon 1 63 NEUPOGEN 63 FDA defined valvulopathy 63 hypercalcemia 63 fatigue abdominal pain 63 thrombocytopenic 63 intravenous vancomycin 63 VFEND 63 % asthenia malaise 63 Medoxomil 63 pericardial effusion 63 RAPTIVA 63 Ramipril 63 risperidone Risperdal 63 paclitaxel eluting stents 63 Ovitrelle R Serostim 63 prucalopride 63 ZIAGEN 63 asthma exacerbation 63 lowest tertile 63 Renal impairment 63 terazosin 63 receiving APTIVUS r 63 mL sec 63 caspofungin 63 REYATAZ R 63 antiretroviral naive 63 plus medroxyprogesterone acetate 63 ® emtricitabine 63 EGYPTIAN POUND 63 μg mL 63 PEG IFN 63 timepoints 63 melphalan prednisone 63 leukocyte count 62 Fluticasone 62 INVEGA ® 62 g dl 62 chronic eosinophilic leukemia 62 DAS# remission 62 peginterferon 62 mg/# hr 62 CR CRu 62 NMIBC 62 vWD 62 Cilostazol 62 Erythropoietic therapies may 62 PROCTOCORT R Cream Hydrocortisone 62 peginterferon alpha 2a 62 CTAP# 62 underwent surgical resection 62 thrombocytopenia 62 Linezolid 62 postoperative morbidity 62 endophthalmitis 62 ritonavir boosted lopinavir 62 Baseline characteristics 62 Postoperative complications 62 NIH CPSI 62 Lubiprostone 62 peg IFN 62 insulin glulisine 62 oral Hycamtin 62 median survivals 62 cyclophosphamide methotrexate 62 darunavir ritonavir 62 posttreatment 62 mRCC 62 NRTI sparing 62 dasatinib Sprycel ®

Back to home page